Effects of Plasmapheresis on Serum Lithium Levels in an ICU Patient with Bipolar Disorder: A Case Study

被引：0

作者：

Lien, Thuy N. T. ^{[1
]}

Mohamed, Sherin M. M. ^{[2
]}

van den Bogaard, Bas ^{[2
]}

Touw, Daan J. ^{[3
]}

Franssen, Eric J. F. ^{[1
]}

机构：

[1] Hosp Pharm Dept OLVG, Oosterpk 9, NL-1091 AC Amsterdam, Netherlands

[2] Intens Care Unit OLVG, Amsterdam, Netherlands

[3] Hosp Pharm Dept UMCG, Groningen, Netherlands

来源：

THERAPEUTIC DRUG MONITORING | 2024年 / 46卷 / 03期

关键词：

therapeutic drug monitoring; plasmapheresis; lithium; bipolar disorder; pharmacokinetics;

D O I：

10.1097/FTD.0000000000001191

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

This is a case description of a patient with bipolar disorder undergoing lithium therapy who received plasmapheresis for neuromyelitis optica spectrum disorder. Plasmapheresis resulted in lower and subtherapeutic serum lithium levels. Using therapeutic drug monitoring, a dose escalation of 80% was necessary to maintain therapeutic serum lithium levels. This underscores the importance of individualized therapy through therapeutic drug monitoring.

引用

页码：281 / 284

页数：4

共 16 条

[1] [Anonymous], Lithium
[2] [Anonymous], Therapeutic Drug Monitoring en Farmacogenetica Monografien
[3] Lithium and angiotensin-converting enzyme inhibitors: Evaluation of a potential interaction
Finley, PR
OBrien, JG
Coleman, RW
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (01) : 68 - 71
[4] Lithium side effects and toxicity: prevalence and management strategies
Gitlin, Michael
[J]. INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2016, 4
[5] Gonzalez Garcia F., 2020, Vademecum Therapeutische Aferese. Sanquin
[6] Hiemke C, 2018, PHARMACOPSYCHIATRY, V51, pE1, DOI [10.1055/s-0037-1600991, 10.1055/s-0043-116492]
[7] Janicak PG., Bipolar Disorder in Adults and Lithium: Pharmacology, Administration
[8] Kamali M, 2017, AMERICAN PSYCHIATRIC ASSOCIATION PUBLISHING TEXTBOOK OF PSYCHOPHARMACOLOGY, 5TH EDITION, P889
[9] KNMP Kennisbank, Monografie: Lithiumcarbonaat. Version 3.2.8
[10] Labbate LA., 2010, Handbook of Psychiatric Drug Therapy, V6th ed, P110

← 1 2 →